Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-20,300
Closed -$3.32M 3408
2026
Q1
$3.32M Sell
20,300
-5,600
-22% -$861K 0.01% 1609
2025
Q4
$4.51M Sell
25,900
-326,987
-93% -$59.7M 0.01% 1369
2025
Q3
$50.8M Buy
352,887
+44,200
+14% +$5.41M 0.07% 345
2025
Q2
$31.1M Buy
+308,687
New +$23.6M 0.04% 528
2025
Q1
Sell
-25,287
Closed -$1.75M 3642
2024
Q4
$1.75M Buy
+25,287
New +$1.82M ﹤0.01% 2143
2024
Q2
Sell
-133,987
Closed -$3.63M 3722
2024
Q1
$3.63M Buy
+133,987
New +$3.75M 0.01% 1624
2023
Q1
Sell
-27,300
Closed -$545K 4178
2022
Q4
$545K Buy
+27,300
New +$528K ﹤0.01% 2906
2018
Q1
Sell
-36,487
Closed -$1.14M 3456
2017
Q4
$1.14M Sell
36,487
-19,400
-35% -$573K ﹤0.01% 2612
2017
Q3
$1.74M Buy
+55,887
New +$1.06M ﹤0.01% 2347
2017
Q1
Sell
-120,500
Closed -$1.59M 3302
2016
Q4
$1.59M Sell
120,500
-77,200
-39% -$1.05M ﹤0.01% 2333
2016
Q3
$2.87M Buy
197,700
+48,400
+32% +$606K 0.01% 1979
2016
Q2
$1.47M Sell
149,300
-34,487
-19% -$402K ﹤0.01% 2368
2016
Q1
$2.33M Buy
+183,787
New +$2.42M ﹤0.01% 2130
2014
Q3
Sell
-48,587
Closed -$971K 2863
2014
Q2
$971K Buy
+48,587
New +$719K ﹤0.01% 2066

Other funds holding INSM

Jim Simons's INSM Position: Q2 2026 in Review

Jim Simons sold out of Insmed (INSM) in Q2 2026, closing a stake of 20,300 shares — an estimated $3.32M sold.

Jim Simons first reported a position in INSM in Q2 2014 and held it in 14 quarters. The position peaked at $50.8M in Q3 2025. 456 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Jim Simons reported no remaining Insmed position as of Q2 2026 after selling out during the quarter.
  • Jim Simons sold 20,300 Insmed shares in Q2 2026, an estimated $3.32M.
  • Jim Simons first reported a position in Insmed in Q2 2014 and held it in 14 quarters.
  • Jim Simons's Insmed position peaked at $50.8M in Q3 2025.
  • 456 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.